These studies showed that the urokinase-type plasminogen activator (uPA)—a serine protease that activates a cascade of extracellular proteinases involved in tissue remodeling—together with its receptor uPAR, plays a significant role in the invasion and neovascularization of GBM. The gene discussed is PLAUR; the disease is glioblastoma.